Sun Q, Lei X, Yang X
Genes Dis. 2025; 12(3):101286.
PMID: 40028033
PMC: 11870203.
DOI: 10.1016/j.gendis.2024.101286.
Song W, Chen X, Wu H, Rahimian N
Eur J Med Res. 2024; 29(1):643.
PMID: 39741306
PMC: 11689626.
DOI: 10.1186/s40001-024-02230-7.
Xia Y, Yu X, Yuan Z, Yang Y, Liu Y
Biology (Basel). 2024; 13(10).
PMID: 39452097
PMC: 11504436.
DOI: 10.3390/biology13100788.
Zang X, He X, Xiao C, Lin Q, Wang M, Liu C
Mol Cancer. 2024; 23(1):207.
PMID: 39334380
PMC: 11438063.
DOI: 10.1186/s12943-024-02124-6.
Gong J, Han G, Chen Z, Zhang Y, Xu B, Xu C
J Transl Med. 2024; 22(1):517.
PMID: 38816735
PMC: 11137954.
DOI: 10.1186/s12967-024-05233-4.
The emerging role and clinical significance of circRNAs in papillary thyroid cancer.
Ma J, Xu J, Zhang X, Quan J
Front Endocrinol (Lausanne). 2024; 15:1351776.
PMID: 38544689
PMC: 10965563.
DOI: 10.3389/fendo.2024.1351776.
The novel circRNA circ_0045881 inhibits cell proliferation and invasion by targeting mir-214-3p in triple-negative breast cancer.
Ren J, Chen W, Zhou Y, Sun J, Jiang G
BMC Cancer. 2024; 24(1):278.
PMID: 38429642
PMC: 10905830.
DOI: 10.1186/s12885-024-12007-0.
Epigenetic modifications: Key players in cancer heterogeneity and drug resistance.
Sadida H, Abdulla A, Al Marzooqi S, Hashem S, Macha M, Akil A
Transl Oncol. 2023; 39:101821.
PMID: 37931371
PMC: 10654239.
DOI: 10.1016/j.tranon.2023.101821.
Role of The circ-HIPK3, circ-PVT1, miR-25, and miR-149 in Response of Breast Cancer Cells to Ionizing Radiation.
Abdollahi E, Mozdarani H
Cell J. 2023; 25(10):688-695.
PMID: 37865877
PMC: 10591259.
DOI: 10.22074/cellj.2023.1995943.1255.
Core fucosylation and its roles in gastrointestinal glycoimmunology.
Zhang N, Zhao L, Zhang Q, Fang H, Song W, Li W
World J Gastrointest Oncol. 2023; 15(7):1119-1134.
PMID: 37546555
PMC: 10401475.
DOI: 10.4251/wjgo.v15.i7.1119.
circSLC4A7 accelerates stemness and progression of gastric cancer by interacting with HSP90 to activate NOTCH1 signaling pathway.
Hui Y, Wenguang Y, Wei S, Haoran W, Shanglei N, Ju L
Cell Death Dis. 2023; 14(7):452.
PMID: 37474578
PMC: 10359325.
DOI: 10.1038/s41419-023-05976-w.
CircIFFO1 suppresses tumor growth and metastasis of cutaneous squamous cell carcinoma by targeting the miR-424-5p/NFIB axis.
Yu H, Liu P, Chen T
Arch Dermatol Res. 2023; 315(9):2585-2596.
PMID: 37405427
DOI: 10.1007/s00403-023-02659-6.
Circ_0010235 confers cisplatin resistance in lung cancer by upregulating E2F7 through absorbing miR-379-5p.
Wang L, Wang D, Xu Z, Qiu Y, Chen G, Tan F
Thorac Cancer. 2023; 14(20):1946-1957.
PMID: 37277864
PMC: 10344743.
DOI: 10.1111/1759-7714.14941.
CREBZF mRNA nanoparticles suppress breast cancer progression through a positive feedback loop boosted by circPAPD4.
Zhou B, Xue J, Wu R, Meng H, Li R, Mo Z
J Exp Clin Cancer Res. 2023; 42(1):138.
PMID: 37264406
PMC: 10233212.
DOI: 10.1186/s13046-023-02701-5.
Role of circ-FOXO3 and miR-23a in radiosensitivity of breast cancer.
Abdollahi E, Mozdarani H, Alizadeh B
Breast Cancer. 2023; 30(5):714-726.
PMID: 37222952
DOI: 10.1007/s12282-023-01463-4.
RNA helicase DDX5-induced circPHF14 promotes gastric cancer cell progression.
Wang J, Han C, Wang J, Peng Q
Aging (Albany NY). 2023; 15(7):2525-2540.
PMID: 36996491
PMC: 10120908.
DOI: 10.18632/aging.204623.
Circular RNAs: implications of signaling pathways and bioinformatics in human cancer.
Hu F, Peng Y, Fan X, Zhang X, Jin Z
Cancer Biol Med. 2023; 20(2).
PMID: 36861443
PMC: 9978890.
DOI: 10.20892/j.issn.2095-3941.2022.0466.
Modulating epigenetic modifications for cancer therapy (Review).
Castro-Munoz L, Ulloa E, Sahlgren C, Lizano M, De La Cruz-Hernandez E, Contreras-Paredes A
Oncol Rep. 2023; 49(3).
PMID: 36799181
PMC: 9942256.
DOI: 10.3892/or.2023.8496.
Circular RNA circ_0026218 Suppressed Atherosclerosis Progression via miR-338-3p/SIRT6 Axis.
Yang L, Chen W, Li B, Hu Y, Lu H, Zhang P
Biomed Res Int. 2023; 2023:5647758.
PMID: 36733404
PMC: 9889145.
DOI: 10.1155/2023/5647758.
circIPO7 dissociates caprin-1 from ribosomes and inhibits gastric cancer cell proliferation by suppressing EGFR and mTOR.
Liu J, Niu L, Hao J, Yao Y, Yan M, Li H
Oncogene. 2023; 42(13):980-993.
PMID: 36732659
PMC: 10038803.
DOI: 10.1038/s41388-023-02610-z.